13F-HR filed by EcoR1 Capital, LLC
EcoR1 Capital, LLC filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-15, with 59 holding rows worth $3,953,710,314.
- Accession
- 0000935836-24-000391
- Filer
- CIK 1587114
- Filed
- 2024-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 59 entries on the cover page, a total value of $3,953,710,314 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,953,710,314 with VALUE read as dollars as filed, 13F file number 028-16764. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 11,357,425 | $667,589,442 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 11,584,280 | $286,942,616 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 6,726,491 | $277,669,548 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 1,919,835 | $248,541,839 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 4,155,375 | $194,513,104 | dollars as filed | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 5,756,268 | $185,351,830 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 7,521,024 | $169,373,460 | dollars as filed | |
| ZYMEWORKS INC | 98985Y108 | COM | 13,437,473 | $141,362,216 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 5,806,871 | $123,860,558 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 1,013,952 | $122,100,100 | dollars as filed | |
| XENCOR INC | 98401F105 | COMMON STOCK | 5,330,416 | $117,962,106 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 5,991,479 | $110,782,447 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 13,330,736 | $105,846,044 | dollars as filed | |
| IMMUNOME INC | 45257U108 | COM | 3,879,415 | $95,743,962 | dollars as filed | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 1,389,276 | $94,693,052 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 19,364,688 | $86,753,802 | dollars as filed | |
| MORPHIC HLDG INC | 61775R105 | COM | 2,384,384 | $83,930,317 | dollars as filed | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 19,209,643 | $69,923,101 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 1,271,342 | $64,711,308 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 5,618,779 | $63,492,203 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 3,418,068 | $46,998,435 | dollars as filed | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 27,404,070 | $43,298,431 | dollars as filed | |
| Tscan Therapeutics Inc | 89854M101 | COM | 5,000,000 | $39,700,000 | dollars as filed | |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 3,917,546 | $36,472,353 | dollars as filed | |
| THIRD HARMONIC BIO INC | 88427A107 | COM | 3,182,444 | $30,042,271 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 2,071,450 | $28,482,438 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 650,000 | $27,280,500 | dollars as filed | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 1,999,249 | $27,269,756 | dollars as filed | |
| LENZ THERAPEUTICS INC | 52635N103 | COM | 1,219,774 | $27,237,553 | dollars as filed | |
| ATEA PHARMACEUTICALS INC | 04683R106 | COMMON STOCK | 6,145,861 | $24,829,278 | dollars as filed | |
| ALECTOR INC | 014442107 | COMMON STOCK | 4,056,548 | $24,420,419 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 1,250,385 | $22,807,022 | dollars as filed | |
| NKARTA INC | 65487U108 | COMMON STOCK | 2,000,000 | $21,620,000 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 900,000 | $20,799,000 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 300,000 | $20,493,000 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 75,000 | $20,028,000 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 757,576 | $19,333,340 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 6,117,400 | $18,658,070 | dollars as filed | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 1,250,000 | $16,600,000 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 700,000 | $14,931,000 | dollars as filed | call |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 187,500 | $12,412,500 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 427,039 | $12,123,637 | dollars as filed | |
| KYVERNA THERAPEUTICS INC | 501976104 | COMMON STOCK | 450,000 | $11,178,000 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 9,195,404 | $10,850,577 | dollars as filed | |
| ALLOVIR INC | 019818103 | COM | 11,294,585 | $8,526,282 | dollars as filed | |
| KODIAK SCIENCES INC | 50015M109 | COM | 1,613,600 | $8,487,536 | dollars as filed | |
| GENERATION BIO CO | 37148K100 | COM | 2,046,867 | $8,330,749 | dollars as filed | |
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 10,167,043 | $7,055,928 | dollars as filed | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 2,884,357 | $6,604,889 | dollars as filed | |
| ALIGOS THERAPEUTICS INC COM NEW | 01626L105 | Stock | 6,389,468 | $6,261,679 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 500,000 | $4,955,000 | dollars as filed | |
| PRIME MEDICINE INC | 74168J101 | COM | 700,000 | $4,900,000 | dollars as filed | |
| NUVATION BIO INC | 67080N119 | WARR | 963,333 | $3,506,532 | dollars as filed | |
| HOOKIPA PHARMA INC | 43906K100 | COM | 4,595,024 | $3,271,657 | dollars as filed | |
| SURROZEN INC | 86889P117 | *W EXP 08/01/203 | 66,665 | $1,047,307 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 566,879 | $963,694 | dollars as filed | |
| CAREMAX INC | 14171W111 | *W EXP 06/08/202 | 100,000 | $482,000 | dollars as filed | |
| KODIAK SCIENCES INC | 50015M109 | COM | 51,100 | $268,786 | dollars as filed | call |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 1,000 | $39,640 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000935836-24-000391 | this filing | 2024-05-15 | acceptance time not in the bulk data set |